# Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis

> **NCT07001878** · PHASE4 · RECRUITING · sponsor: **Nova Scotia Health Authority** · enrollment: 24 (estimated)

## Conditions studied

- Psychosis
- Cannabis Use

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT07001878
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-18
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-12-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07001878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07001878, "Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07001878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*